Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions

Terracciano,Daniela; Mazzarella,Claudia; Cicalese,Marcellino; Galzerano,Sonia; Apostolico,Gianfranco; di Carlo,Angelina; Mariano,Angela; Cecere,Ciriaco; Macchia,Vincenzo

doi:10.3892/ol_00000082

Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions

Authors:
- Daniela Terracciano
- Claudia Mazzarella
- Marcellino Cicalese
- Sonia Galzerano
- Gianfranco Apostolico
- Angelina di Carlo
- Angela Mariano
- Ciriaco Cecere
- Vincenzo Macchia
View Affiliations

Affiliations: Dipartimento di Biologia e Patologia Cellulare e Molecolare ‘L. Califano’, Università degli Studi di Napoli Federico II, 80131 Napoli, Italy
Published online on: May 1, 2010 https://doi.org/10.3892/ol_00000082
Pages: 465-471

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A panel of tumour markers including carcinoembryonic antigen (CEA), carbohydrate antigen (Ca)15-3, Ca125 and Ca19-9 were measured in the lysate of sediments and in the supernatants of pleural effusions of patients with benign and malignant disease. The tumour markers were also measured in the serum of the same patients. Of these patients, 32 had benign diseases (12 trasudative effusions associated with cirrhosis and 20 with non-malignant exudates: 12 pleuritis and 8 other inflammations) and 103 had malignant effusions (37 breast cancers, 29 lung cancers, 10 ovary cancers, 6 kidney cancers, 11 mesotheliomas and 10 lymphomas). We showed the highest level of CEA in pleural effusions of lung cancer followed by that in pleural effusions of breast cancer; whereas Ca15-3 was very high in the pleural effusions of breast and lung cancer. Concerning the lysate of sediment, CEA was high in the pleural effusions of patients with lung cancer and Ca15-3 in those of patients with breast cancer. The other markers are much less useful. For the remaining tumours, none of the markers tested appear to aid in the diagnosis of disease. In conclusion, our data suggest that the combined determination of tumour markers on supernatants and sediments of pleural effusion may provide additional information on the nature of pleural effusion, especially for cases with negative cytology.

View Figures

View References

1	Light RW, Macgregor MI, Luchsinger PC and Ball WC Jr: Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 77:507–513. 1972. View Article : Google Scholar : PubMed/NCBI
2	Gazquez I, Porcel JM, Vives M, Vicente de Vera MC, Rubio M and Rivas MC: Comparative analysis of Light's criteria and other biochemical parameters for distinguishing transudates from exudates. Respir Med. 92:762–765. 1998.
3	Paramothayan NS and Barron J: New criteria for the differentiation between transudates and exudates. J Clin Pathol. 55:69–71. 2002. View Article : Google Scholar : PubMed/NCBI
4	Heffner JE, Sahn SA and Brown LK: Multilevel likelihood ratios for identifying exudative pleural effusions (^*). Chest. 121:1916–1920. 2002. View Article : Google Scholar : PubMed/NCBI
5	Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A and Macchia V: New approaches in the diagnostic procedure of malignant pleural effusions. Oncol Rep. 12:79–83. 2004.PubMed/NCBI
6	Fenton KN and Richardson JD: Diagnosis and management of malignant pleural effusions. Am J Surg. 170:69–74. 1995. View Article : Google Scholar
7	Marel M, Stastny B, Melinova L, Svandova E and Light RW: Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest. 107:1598–1603. 1995. View Article : Google Scholar : PubMed/NCBI
8	Menzies R and Charbonneau M: Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med. 114:271–276. 1991. View Article : Google Scholar : PubMed/NCBI
9	San Jose ME, Alvarez D, Valdes L, Sarandeses A, Valle JM and Penela P: Utility of tumour markers in the diagnosis of neoplastic pleural effusion. Clin Chim Acta. 265:193–205. 1997.PubMed/NCBI
10	Paganuzzi M, Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S and Felletti R: Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest. 119:1138–1142. 2001. View Article : Google Scholar : PubMed/NCBI
11	Galbis Caravajal JM, Benlloch Carrion S, Sanchez Paya J, Mafe Madueno JJ, Baschwitz Gomez B and Rodriguez Paniagua JM: Prognostic value of the carcinoembryonic antigen found in pleural lavage fluid from patients with lung carcinoma. Arch Bronconeumol. 41:185–188. 2005.PubMed/NCBI
12	Ghayumi SM, Mehrabi S, Doroudchi M and Ghaderi A: Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathol Oncol Res. 11:236–241. 2005. View Article : Google Scholar : PubMed/NCBI
13	Antonangelo L, Vargas FS, Seiscento M, Bombarda S, Teixera L and Sales RK: Clinical and laboratory parameters in the differential diagnosis of pleural effusion secondary to tuberculosis or cancer. Clinics. 62:585–590. 2007. View Article : Google Scholar : PubMed/NCBI
14	Fetsch PA and Abati A: Immunocytochemistry in effusion cytology: a contemporary review. Cancer. 93:293–308. 2001. View Article : Google Scholar : PubMed/NCBI
15	Kjeldsberg C and Knight J: Pleural and Pericardial Fluids Body Fluids. 3rd edition. ASCP; Chicago: pp. 159–222. 1993
16	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
17	Bedrossian CW: Diagnostic problems in serous effusions. Diagn Cytopathol. 19:131–137. 1998. View Article : Google Scholar : PubMed/NCBI
18	Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U and Bocking A: Diagnostic accuracy of effusion cytology. Diagn Cytopathol. 20:350–357. 1999. View Article : Google Scholar : PubMed/NCBI
19	Kuralay F, Tokgoz Z and Comlekci A: Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clin Chim Acta. 300:43–55. 2000. View Article : Google Scholar : PubMed/NCBI
20	Shitrit D, Zingerman B, Shitrit AB, Shlomi D and Kramer MR: Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3 and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist. 10:501–507. 2005. View Article : Google Scholar : PubMed/NCBI